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Abstract The Saccharomyces cerevisiae gene PPZ1 codes for 
a 692-residues protein that shows in its carboxyl-terminal half 
about 60% identity with the catalytic subunit of mammafian and 
yeast protein phosphatase-1 and that is involved in salt homeosta- 
sis. The complete PPZ1 protein has been succesfully expressed 
as a soluble glutathione-S-transferase fusion protein. The recom- 
binant protein, after purification by a single affinity chromatogra- 
phy step, displayed phosphatase activity towards a number of 
substrates, including myefin basic protein, histone 2A and casein, 
but was ineffective in dephosphorylating glycogen phosphorylase. 
It was also active towards p-nitrophenylphosphate. The activity 
was severalfold increased by the presence of Mn 2+ ions and by 
limited trypsinolysis. The enzyme was inhibited by okadaic acid 
and microcystin-LR at concentrations comparable to what is 
found for type 1 protein phosphatase although it was much less 
sensitive to inhibitor-2. The recombinant protein was 
phosphorylated in vitro by cAMP-dependent protein kinase, pro- 
tein kinase C and casein kinase-2. Phosphorylation affected pref- 
erentially sites located in the amino-terminal half of the protein 
and did not alter the activity of the phosphatase. 
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1. Introduction 
Ser/Thr protein phosphatases have been traditionally classi- 
fied in four groups, namely type 1, 2A, 2B and 2C, on the basis 
of their enzymological properties. With the exception of type 
2C, these enzymes are found as oligomers composed of one 
catalytic subunit and one or more regulatory subunits. The 
elucidation of the primary structure of their catalytic subunits 
revealed that type 1 (PP-lc), 2A (PP-2Ac) and 2B enzymes are 
related in sequence (see [1] for review) and was the starting 
point for the identification of a number of DNA clones from 
mammals, Drosophila and both fission and budding yeast en- 
coding proteins tructurally related but clearly distinct from the 
above mentioned enzymes [2,3]. In some cases, these novel 
phosphatases have been found in a variety of species and share 
with PP-Ic and PP-2Ac the characteristic of being extremely 
conserved in their primary structure. For instance, this is the 
situation for PPX, a PP-2Ac-related protein that has been 
cloned from mammals [4,5], Drosophila [5] and higher plants [6]. 
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However, in most cases these novel forms have been only iden- 
tified so far in a single species. The biological role, as well as 
the enzymological characteristics and the regulation of these 
proteins are, almost without exception, completely unknown. 
The genome of the budding yeast Saccharomyces cerevisiae 
encodes not less than five of these novel putative phosphatases, 
namely SIT4/PPH1 [7], PPH3 [8], PPZ1 and PPZ2 [9-11] and 
PPQ [12], although PCR experiments have suggested the exis- 
tence of additional related genes [13]. The complete PPZ1 gene 
was initially cloned in our laboratory some time ago [9] and 
found to encode a protein of 692 amino acids whose carboxyl- 
terminal half could be aligned with PP-lc from a large variety 
of species (about 60% of identity). On the contrary, its large 
amino-terminal extension was unrelated to Ser/Thr 
phosphatases and contained a remarkably high number of Ser 
residues. A second, closely related gene, named PPZ2 has been 
also cloned [10,11]. We have found that simultaneous disrup- 
tion of both genes results in a phenotype of hypersensitivity to 
caffeine that leads to cell lysis unless the growth medium was 
osmotically stabilized [14]. The idea that one of the biological 
roles of PPZI/PPZ2 is related to the maintenance of cell integ- 
rity is in keeping with the isolation of gene PPZ2 as a multicopy 
suppressor of the lytic defect associated with the disruption of 
the gene SLT2IMPKI ,  which codes for a MAP kinase homo- 
logue [11]. Very recently, we have proven that PPZllPPZ2 are 
key determinants in salt homeostasis. Cells lacking PPZ1 and 
PPZ2 tolerate high concentrations of Na + and Li + cations as 
a result of an increase in the efflux of these cations. Our data 
indicate that the ENA1 gene, encoding the putative P-type 
ATPase acting as a major determinant of cation efflux in yeast 
[l 5] is a molecular target for PPZ1. Our laboratory is presently 
characterizing the biological role and enzymological properties 
of the PPZ proteins. As one of the steps in this direction, we 
report here the bacterial expression of PPZ 1 and the character- 
ization of the recombinant enzyme. 
2. Materials and methods 
2.1. Strains and media 
E. coli Strain NM522 was employed for both construction fvectors 
and expression experiments. Standard methods were used for the con- 
struction of plasmids [16]. Bacteria were grown in LB medium (1% 
tryptone, 0.5% yeast extract and 1% NaCI) supplemented with the 
appropriate antibiotic when needed for plasmid maintenance. 
2.2. Expression of recombinant PPZ1 using the pGEX-KT vector 
The complete open reading frame ncoding PPZ1 was fused to the 
GST moiety as follows. PCR reactions were carried out using the 
PPZ-A plasmid and oligonucleotides 5' CGGGATCCATGGGTAA- 
TTCAAGTTCA 3' and 5' CCAAGCTTACTGTTGAGATTCGTT 3' 
(underlined are BamHI and HindIII sites) to create a BamHI site in 
front of the initiating methionine codon and a HindIIl site right after 
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the stop codon of the PPZ1 open reading frame (plasmid PPZ-A is the 
original 4.5 kbp clone isolated from a size-selected genomic library 
constructed in pUC19 [9] and contains the complete PPZ1 gene) PCR 
conditions were: 94°C for 1.5 min, 50°C for 2 min and 72°C for 3 min. 
A final extension step of 3 min at 72 ° was added. The PCR product was 
a single band of about 2.1 kbp that was digested with BamHI and 
HindIII and ligated into the BamHI and HindIII sites of plasmid pSP72 
(Promega) to yield pSP72-PPZ1. This plasmid was digested with PvuII 
and BamHI and ligated into the SmaI and BamHI sites of the expres- 
sion vector pGEX-KT [17,18] creating the pGEX-KT/PPZ 1 construct. 
Twenty five ml of a culture of NM522 E. coli cells carrying the 
pGEX-KT/PPZ1 plasmid were grown overnight at 37°C and then used 
to inoculate 1 liter of LB medium containing ampicillin. Growth at 
370C was resumed until the absorbance at600 nm was 0.8-1. Isopro- 
pylthiogalactoside was then added to a final concentration of 1 mM, 
and the culture was grown for an additional 3hours at 28°C. The cells 
were harvested by centrifugation, resuspended in 20 ml of STET buffer 
(50 mM Tris pH 8.0, 150 mM NaCl, 1 mM EDTA, Triton X-100 1%) 
containing 0.1% (v/v) fl-mercaptoethanol, 1 mM phenylmethylsulfonyl 
fluoride, 0.5 mM benzamidine, 1Hg/ml eupeptin and 1/.tg/ml pepstatin. 
Bacteria were lysed by sonication and the lysate was clarified by centrif- 
ugation at 4°C (10 min, 7000 x g). Aliquots of the supernatant were 
stored at -80°C. For affinity purification of the GST-PPZ1 recombi- 
nant protein, 2 ml of bacterial supernatant prepared as described above 
were mixed with 1 ml of a 50% (v/v) suspension of glutathione-agarose 
beads (Sigma Chem. Co.) and incubated for 30 min at 40C with gentle 
shaking. The agarose beads were washed four times with STET buffer 
and, finally, once with 50 mM Tris pH 8.0, 1 mM EDTA. The fusion 
protein was eluted with 10 mM glutathione in 50 mM Tris pH 7.5, 2 
mM dithiothreitol, 150 mM NaCI [17,19]. Cleavage of the GST moiety 
was carried out essentially as described in [18] and was monitored by 
SDS-polyacrylamide g l electrophoresis. 
2.3. Phosphatase assays 
Phosphatase ubstrates were phosphorylated byrabbit skeletal mus- 
cle protein kinase A in the presence of 0.2 mM [y-32p]ATP (0.8-1 x 106 
cpm/nmol) and 10 mM magnesium acetate. The substrates used were 
myelin basic protein (6.75 nmol of phosphate/rag of protein), histone 
2-A (17 nmol/mg protein), casein (22 nmol/mg protein). Phosphorylase 
b was fully converted to the active a form by phosphorylation with 
purified phosphorylase kinase [20]. The phosphatase assays were car- 
ried out according to methods previously described [21] on a final 
volume of 30,ul. The final concentrations of the substrates were of 135 
/lg/ml (1 mg/ml for phosphorylase) and the concentration f recombi- 
nant PPZ1 in the assay was between 1 and 5/zg/ml. Unless otherwise 
stated, 25 mM Mn2C1 was present in the PPZ1 assays. One unit of 
phosphatase was defined as the amount of enzyme which releases one 
/lmol of phosphate/min from 32p-labeled myelin basic protein, p-nitro- 
phenylphosphatase ctivity was measured as described in [22]. One unit 
of activity is defined as 1/tmol ofp-nitrophenylphosphate ydrolyzed/ 
min. 
The effect of limited trypsinolysis on phosphatase activity was tested 
by incubation of the above mentioned mixture (without 32p-labeled 
substrate) with trypsin (200/zg/ml) for five min at 30°C. Soybean 
trypsin inhibitor was added to a final concentration of 0.75 mg/ml at 
the end of the incubation. Phosphatase activity was then determined as 
described above, after addition of the 32p-labeled substrate. 
Tyr-protein phosphatase activity was assayed with modified ly- 
sozyme as substrate. The preparation and phosphorylation f the sub- 
strate and the assay conditions were as described [23]. 
2.4. Phosphorylation of recombinant PPZ1 
Recombinant GST-PPZ1 was phosphorylated in vitro as follows: 90 
ng of the protein were incubated for 30 min at 30°C in a final volume 
of 20/zl in the presence of 37.5 mM Tris pH 7.5, 0.1 mM [y-32p]ATP 
(0.1/zCi/nmol), 1 mM magnesium acetate. The mixture included prep- 
arations of either abbit skeletal muscle PK-A (125 mU), rat liver CK-2 
(15 mU) or rat brain PK-C (30 mU). When the latter kinase was 
employed, 0.1 mM calcium chloride, 0.15 mg/ml of phosphatidylserine 
and 15/lg/ml of diolein were also included in the reaction mixture. After 
incubation samples were boiled and analyzed by electrophoresis. In the 
case of PK-A, the commercial preparations (Sigma Chemical Co.) used 
for testing the effect of phosphorylation  PPZ1 activity, were sub- 
jected to gel filtration in a Superdex 75 FPLC column (Pharmacia) to 
remove a termostable, low molecular weight inhibitory activity of the 
phosphatase present in the kinase preparations. 
2.5. Other techniques 
2.5.1. Electrophoresis of proteins. Protein samples were boiled in 50 
mM Tris-HC1 pH 6.8, 100 mM dithiothreitol, 2% (w/v) SDS, 0.1% (w/v) 
Bromophenol blue and 10% (v/v) glycerol. Electrophoresis in SDS- 
polyacrylamide gels was performed as described [24]. 
2.5.2. Determination ofprotein concentration. The concentration f 
proteins was determined by the Bradford's method [25] using bovine 
serum albumin as a standard. 
2.5.3. Purification of PP-lc and inhibitor-2. The catalytic subunit 
of PP-I and inhibitor-2 were isolated from rabbit skeletal muscle as 
described [26,27] 
2.5.4. Cyanogen bromide cleavage and phosphoaminoacid analy- 
sis. For cyanogen bromide analysis amples of previously phosphor- 
ylated PPZI were boiled for five rain and digested at room temperature 
for 24 h in a 70% (v/v) formic acid solution containing 50 mg/ml of 
CNBr. Samples were evaporated to dryness and electrophoresed in 
SDS-polyacrylamide g ls. In the case of samples phosphorylated with 
CK-2, the GST-PPZI protein was replaced by the GST fragment and 
run in parallel to identify the radioactive fragments derived from the 
autophosphorylated kinase. For phosphoamino acid analysis, samples 
of previously phosphorylated PPZ1 were electrophoresed in SDS-poly- 
acrylamide gels and the fragment of the gel containing the 110 kDa 
radioactive band was excised, washed with water and incubated at 
110°C in the presence of 6 M HC1 for 4 h. After evaporation todryness, 
samples were supplemented with phosphoaminoacid standards and 
subjected to two-dimensional thin-layer electrophoresis on cellulose 
plates at pH 1.9 and 3.5, successively, as described [28]. 
3. Results and discussion 
3.1. Expression o f  PPZ1 as a GST-fused protein 
Initial attempts to express the complete PPZ1 open reading 
frame, using the pT7-7 system [29], were unsuccesful. An (insol- 
uble) expression product was obtained, however, with a con- 
struct containing the putative catalytic domain (residues 297 
692). Attempts to renature this fragment yielded a soluble ma- 
terial with a detectable but very low activity towards 32p-labeled 
myelin basic protein (0.10 mU/mg) that could be enhanced to 
0.35 mU/mg by limited trypsinolysis. 
Since the results obtained using a T7-based system were not 
satisfactory, a second strategy was devised, based on the in 
frame fusion of the complete PPZ 1 open reading frame with the 
26 kDa fragment of the GST present in the pGEX-KT  vector 
[18]. After induction of the cultures with isopropylthiogalacto- 
side, electrophoresis of bacterial buffered extracts revealed the 
presence of a soluble protein with an estimated molecular mass 
of about 110 kDa which was not present in uninduced cultures. 
This protein was purified in a single step using glutathione- 
agarose affinity chromatography (Fig. 1). Approximately 2~4 
mg of the recombinant protein were recovered from 1 liter of 
bacterial culture. An important parameter in the expression 
experiments was the temperature of the culture during induc- 
tion: expression at temperatures higher than 28°C produced 
essentially insoluble protein. Some preparations contained var- 
iable amounts of a shorter polypeptide with an estimated mo- 
lecular mass of 32 kDa (i.e. the polypeptide running close to the 
electrophoretic front in lane 3 of Fig. 1) that consisted of the 
GST moiety plus the first 45 50 amino acids of the PPZ1 
protein. Evidence for the nature of this fragment are that it 
binds again to the column when submitted to a second chrom- 
atography in a glutathione-agarose affinity system. Further- 
more, the expression of the N-terminal half of PPZ1 (from 
amino acid 1 to 319) as a GST-fusion protein using the same 
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Fig. 1. Expression of recombinant PPZ1 using the pGEX-KT vector. The diagram on the left shows the pGEX-KT/PPZ1 construct used for 
expression. On the right, a Coomassie blue-stained lectrophoretic analysis of E. coil extracts from cells transformed with the plasmid pGEX-KT/ 
PPZI, before induction (1) and after three hours in the presence of 1 mM isopropylthiogalactoside (2) ispresented. The recombinant protein was 
purified by glutathione-agarose chromatography and is shown in lane 3. Note the presence ofthe 32 kDa protein migrating slightly slower than the 
front (see the main text). Lane M, standard molecular weight markers. 
vector also yields the 32 kDa fragment in addition to the ex- 
pected expression product (not shown). The 110 kDa GST- 
PPZI protein can be separated from the 32 kDa fragment by 
ion exchange chromatography in a Mono Q column (Pharma- 
cia). 
3.2. Catalytic properties of  recombinant PPZ1 
The recombinant PPZ1 was active as phosphatase on differ- 
ent substrates, as shown in Table 1. Interestingly, it did not 
show any activity on glycogen phosphorylase, a well-known 
substrate for protein phosphatases-1 and 2A. We found the 
most suitable protein substrate to be myelin basic protein 
phosphorylated by PK-A. Using this substrate, the effect of 
partial trypsinolysis on the activity of the enzyme was studied. 
As shown in Table 1, treatment with trypsin resulted in a 6-fold 
increase in activity. The recombinant protein also displayed 
activity towards p-nitrophenyl phosphate. A noticeable activity 
towards p-nitrophenyl phosphate has been reported in the case 
of bacterially expressed PP-Ic [30], although there are contra- 
Table l 
Phosphatase activity of recombinant PPZI 
Substrate Specific activity 
(mU/mg protein) 
Myelin basic protein 
- trypsin 16.9 + 0.4 
+ trypsin 107.8 + 14.5 
Histone 2A 10.5 + 0.9 
Casein 2.2 + 1.2 
Phosphorylase n.d. 
p-Nitrophenyl phosphate l 18.0 + 9.8 
Tyr(P)-lysozyme n.d. 
Substrates were assayed as described insection 2, in the presence of25 
mM of MnC12. Protein substrates were phosphorylated with cAMP- 
dependent protein kinase or, in the case of phosphorylase, with 
phosphorylase kinase. The concentration fp-nitrophenol phosphate 
in the assay was 5 mM. n.d. indicates non-detectable activity. Results 
are means + S.E.M. of three different experiments. 
dictory reports regarding the ability of native PP-1 c to dephos- 
phorylate the mentioned nonprotein substrate. For another 
Ser/Thr phosphatase (PP-2A) Goris et al. [3 l] reported acorre- 
lation between p-nitrophenyl phosphatase activity and 
phosphotyrosyl activity. However, we observed that PPZ1 was 
unable to dephosphorylate Tyr-phosphorylated lysozyme, 
which is a commonly used substrate for Tyr-protein 
phosphatases [32]. All properties tested of the recombinant 
GST-PPZ1 polypeptide (for instance: specific activity, incapac- 
ity to dephosphorylate phosphorylase, dependence of Mn 2+, 
sensitivity to inhibitors) were essentially identical to those of the 
product resulting from the cleavage of the thrombin recogni- 
tion sequence that is present in the boundary between the GST 
polypeptide and the PPZ1 open reading frame. Therefore, the 
complete GST-PPZ1 was used routinarily for characterization. 
The presence of variable amounts of the 32 kDa fragment did 
not affect the catalytic properties of the recombinant GST- 
PPZ1, as observed after further purification of the 110 kDa 
GST-PPZ1 protein by ion exchange chromatography on a 
Mono Q column. 
The PPZ1 activity could be inhibited by fluoride 
(ICs0 = 9.3 + 0.9 mM) and ATP (IC50 = 2.4 + 0.3 mM). When 
the dependence on divalent cations was tested using myelin 
basic protein as substrate (Fig. 2), it was found that Mg 2+ and 
Ca 2+ at a concentration of 1 mM were unable to affect the 
activity of the phosphatase. However, addition of 1 mM of 
EDTA (but not EGTA) resulted in a modest (35%) decrease in 
activity. Interestingly, the activity increased fourfold in the 
presence of I mM Mn 2+, and up to sixfold when the concentra- 
tion of Mn 2+ was increased in the interval 1-25 mM. No activa- 
tion was detected at concentrations below 0.1 raM. These con- 
centrations are much higher than those required for bacterially 
expressed PP- 1, which was fully activated by 0.1 mM Mn 2+ [30]. 
It is worth noting that in the case of PP-1, the dependence of
Mn 2+ is a characteristic of the bacterially expressed enzyme but 
not of the native phosphatase. When refolded in the presence 
of inhibitor-2, a specific cytoplasmic protein inhibitor, bacteri- 
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Fig. 2. Effect of different effectors on the recombinant PPZI phosphat- 
ase activity. 0.05 mU/ml of purified recombinant PPZI was assayed (see 
section 2) on 32P-labeled myelin basic protein in the presence ofdifferent 
effectors at a final concentration f 1 mM. Results are shown as per- 
centage of the activity in absence of the effector and are 
means + S.E.M. of 5 experiments. 
ally expressed PP-lc became Mn2+-independent [33]. Mn 2+ was 
also found to be essential for the renaturation of PP-lc ex- 
pressed in insect cells, but subsequently the renatured enzyme 
was independent of Mn 2+ [34]. The PPZ1 activity displayed 
towards p-nitrophenyl phosphate was completely dependent on 
the presence of Mn 2+ ions (not shown). 
Protein phosphatases-1 and -2A are sensitive to the well- 
known inhibitors okadaic acid and microcystin-LR [35,36]. We 
have found that recombinant PPZ1 is also sensitive to the 
mentioned toxins. As shown in Fig. 3 (left panel), a significant 
inhibition was observed at concentrations of okadaic acid of 
0.1-1/.tM. The phosphatase activity was almost fully inhibited 
by 10 nM of microcystin. The ICs0 calculated for okadaic acid 
and microcystin were of 0.67/tM and 0.65 nM, respectively. 
When the ICs0 of these inhibitors was determined under the 
same conditions for the catalytic subunit of PP1 from rabit 
skeletal muscle the values obtained were 0.14pM and 0.69 nM, 
respectively. These concentrations are within the range of those 
reported in the literature [37]. Therefore, the sensitivity of re- 
combinant PPZ1 and native PP1 to the inhibitors okadaic acid 
and microcystin is quite similar. The sensitivity of PP-lc for 
these inhibitors have been recently attributed to the sequence 
GEFD present in the carboxyl-terminal domain, which is iden- 
tical in PPZ1 (residues 629-632), but corresponds to YRCG in 
PP-2Ac [38]. We have also investigated whether the activity of 
PPZ1 was affected by inhibitor-2, a specific cytoplasmatic pro- 
tein inhibitor of PP-1. As illustrated in Fig. 3 (right panel), 
PPZ1 was only slightly inhibited by micromolar concentrations 
of inhibitor-2. Contrary to what has been reported for PP-1 
holoenzymes (discussed in [37]), the sensitivity of PPZ1 to in- 
hibitor-2 was not increased by prior treatment with trypsin (not 
shown). However, the low sensitivity to inhibitor-2 may not be 
an intrinsic property of PPZ1, since it may at least in part be 
explained by the basic character of the substrate. Indeed, with 
myelin basic protein as substrate, ICs0 of inhibitor-2 acting on 
PP-lc was estimated at 100 nM, in sharp contrast with an IC50 
of 3 + 1 nM (n = 3) with phosphorylase as substrate (not 
shown). A similarly low sensitivity of PP-Ic to inhibitor-2 has 
been noted by others with phosphorylated histone H1 as sub- 
strate [33,39]. 
The primary structure of PPZ1 (C-terminal half) displays 
more homology with PP-lc than with other Ser/Thr-protein 
phosphatases. Our current data reveal that this similarity 
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Fig. 3. Inhibition of recombinant PPZ1 by microcystin, okadaic acid and inhibitor-2. (Left panel) Purified recombinant PPZI was assayed using 
32p-labeled myelin basic protein in the presence of varying amounts ofmicrocystin (open circles) and okadaic acid (closed circles). (Right panel) Rabbit 
muscle PP-lc (closed squares) and recombinant PPZ1 (open squares) were assayed on 32p-labeled myelin basic protein in the presence of varying 
amounts of rabbit muscle inhibitor-2. Results are shown as percentage of the activity in the absence of inhibitors and are means + S.E.M. of 
5 experiments. 
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Fig. 4. In vitro phosphorylation f recombinant PPZ1. Recombinant 
GST-PPZ1 was phosphorylated in vitro by PKA, PKC and CKII as 
described in section 2. Aliquots were electrophoresed on SDS-poly- 
acrylamide gels and autoradiograms prepared. The arrows indicate 
phosphorylated GST-PPZ 1. Lanes labeled as GST denote control sam- 
ples prepared from bacterial cells containing the expression vector 
without he PPZ1 open reading frame. Note the incorporation ofradi- 
oactive phosphate inthe 32 kDa band in the PK-A lane (see main text), 
and the low-Mr radioactive band in the CK-2 lanes, which corresponds 
to the autophosphorylation of the kinase preparation. 
applies also to the catalytic properties. Thus, the high sensitivity 
of PPZ1 to microcystin relative to okadaic acid is characteristic 
of PP-lc but not of PP-2Ac. Also, unlike PP-2Ac, PPZ1 is 
affected by inhibitor-2, although itwas less sensitive then PP-1 c 
in the same assay conditions. The bacterial origin of PPZ1 may 
account for some unusual properties like its dependence of
Mn 2+ and its high p-nitrophenylphosphatase activity. A re- 
markable difference with both PP-1 and PP-2A is the inability 
of PPZI to dephosphorylate glycogen phosphorylase. We sug- 
gest that the N-terminal half of PPZ1 acts as a substrate-spec- 
ifying domain, in much the same way as the substrate specificity 
of PP-lc is dramatically altered by interaction with non-cata- 
lytic subunits like the G-subunit or the M-subunit [37]. 
3.3. In vitro phosphorylation of  recombinant PPZ1 
The analysis of the amino acid sequence of PPZ1 revealed 
the presence of a large number of consensus equences for 
phosphorylation [9]. These included sites for PK-A and PK-C 
(almost without exception present in the amino-terminal half) 
and CK-2 (distributed along the whole molecule). As shown in 
Fig. 4, recombinant PPZ1 was phosphorylated in vitro by all 
three kinases. Incorporation ofphosphate was about 1 mol/mol 
of PPZ1 in the case of PK-A and PK-C, and slightly lower for 
CK-2. PK-A and PK-C, but not CK-2, were able to incorporate 
radioactive phosphate into the 32 kDa band containing a short 
fragment of the amino-terminal half of PPZ1. Phosphoami- 
noacid analysis indicated that both PK-A and PK-C 
phosphorylated exclusively Ser residues, whereas CK-2 was 
able to phosphorylate both Ser and Thr (not shown). Cyanogen 
bromide analysis revealed in all cases incorporation of radioac- 
tive phosphate into two large fragments of 20 and 21 kDa (Fig. 
5). Phosphorylation f the 21 kDa fragment was further con- 
firmed by in vitro phosphorylation f the solubilized polypep- 
tide resulting of expression on a pT7-7 vector of the C-terminal 
half of PPZ1, which contains the mentioned fragment. It is 
remarkable that the presence of PK-A or PK-C sites in the 21 
kDa CNBr fragment is not evident from computer analysis of 
the primary sequence of the protein. PK-A, and to a minor 
extent PK-C, were also able to phosphorylate r sidues located 
in the 14 kDa amino-terminal CNBr fragment. The incorpora- 
tion of radioactive phosphate into the 32 kDa expression prod- 
uct (see Fig. 4) indicates the presence of PK-A and PK-C 
phosphorylation sites within the 40-50 first residues, which is 
in accordance with the prediction from the primary sequence 
of the protein. 
The confirmation of the presence of phosphorylation sites in 
PPZ1 raised the question of whether or not phosphorylation 
might regulate the activity of the phosphatase. Therefore,we 
determined phosphatase activity in samples of PPZI previously 
phosphorylated in vitro by the mentioned kinases and we found 
that phosphorylation f PPZ1 by PK-A, CK-2 or PK-C did not 
result in changes in phosphatase activity. On the other hand, 
we have immunoprecipitated PPZ1 from crude extracts pre- 
PK-A, PK-C 
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Fig. 5. Schematic representation of the results of the CNBr analysis after phosphorylation f recombinant PPZ1 with different protein kinases. The 
GST moiety is not represented. The carboxyl-terminal h lf of PPZ1 is denoted as a diagonally striped box. Vertical stripes in the amino-terminal 
region indicate a high concentration f predicted phosphorylation sites. The localization of Met residues in the PPZ1 molecule is indicated below 
the expected fragments resulting from CNBr treatment. The double headed arrow indicates the fragment of PPZ1 attached to the GST moiety in 
the 32 kDa expression product. The black box denotes the region of PPZ1 included in the product of expression of the pT7-7 based construct. 
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pared from yeast cells exponentially growing in rich medium 
containing [32p]phosphate and the results obtained indicate that 
the PPZ1 protein is not labeled in vivo. These findings might 
be interpreted as evidence against he idea that phosphorylation 
is involved in the regulation of the enzyme. However, this 
possibility cannot be ruled out. For instance, changes in phos- 
phatase activity might occur upon phosphorylation by a ki- 
nase(s) other(s) than the enzymes employed here. It might still 
be possible that phosphorylation might occur in vivo only 
under specific stimuli and that its biological role would not be 
the regulation of the enzyme activity but, for instance, the 
intracellular localization of the protein. 
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